Shanghai Henlius Biotech Inc.

04/28/2021 | Press release | Distributed by Public on 04/28/2021 03:35

VOLUNTARY ANNOUNCEMENT - SERPLULIMAB INJECTION (RECOMBINANT HUMANISED ANTI-PD-1 MONOCLONAL ANTIBODY INJECTION, ORIGINAL PROJECT CODE: HLX10) HAS BEEN GRANTED PRIORITY REVIEW BY[...]